
ARS
5 Projects, page 1 of 1
- RCGP,ECDC,UNIBAS,GSK Bio,DH,NOVARTIS,AGENZIA DI TUTELA DELLA SALUTE DELLA VAL PADANA,SOSETE,IDIAP Jordi Gol,SYNAPSE RESEARCH MANAGEMENT PARTNERS SL,RIVM,Ministry of Health,SANOFI PASTEUR SA,ERASMUS MC,Tampere University,University of Surrey,SSI,ARS,KI,Sciensano (Belgium),EU,TAMPERE UNIVERSITY,ASL CREMON,AUH,OU,MSD,P95,LSHTM,TAK,Janssen Vaccines (f.k.a. Crucell Holland B.V.),PFIZER,AEMPS,EMEAFunder: European Commission Project Code: 115557
more_vert assignment_turned_in Project2009 - 2012Partners:ISS, DEPARTAMENT DE SALUT - GENERALITAT DE CATALUNYA, IREFREA, API, ARS +28 partnersISS,DEPARTAMENT DE SALUT - GENERALITAT DE CATALUNYA,IREFREA,API,ARS,STAP,LJMU,University of Bergen,NVC FINLAND,EUROPAISCHES ZENTRUM FUR WOHLFAHRTSPOLITIK UND SOZIALFORSCHUNG,A.S.L. CITTA DI MILANO AZIENDA SANITARIA LOCALE,Addiction Switzerland,THL,INPES,CIMH,Stockholm University,UWE,TUD,ECLECTICA,CVUAKA,IPiN,University of Twente,University of York,Institute for Research and Development “Utrip”,SIRUS,PETER DAVID ANDERSON,KCL,Corvinus University of Budapest,PARPA,HCPB,ZEUS,UM,TRIMBOSFunder: European Commission Project Code: 223059more_vert assignment_turned_in Project2008 - 2012Partners:UPF, ERASMUS MC, UniMiB, NEUROLESI, SOSETE +10 partnersUPF,ERASMUS MC,UniMiB,NEUROLESI,SOSETE,University of Aveiro,AstraZeneca (Sweden),USC,LSHTM,FUNDACIO INSTITUT MAR D INVESTIGACIONS MEDIQUES IMIM,University of Nottingham,PHARMO,UNIVERSITE DE BORDEAUX,ARS,AUHFunder: European Commission Project Code: 215847more_vert assignment_turned_in Project2013 - 2018Partners:Novo Nordisk, Universitätsklinikum Erlangen, GU, MRC, EuroRec +61 partnersNovo Nordisk,Universitätsklinikum Erlangen,GU,MRC,EuroRec,University of Lübeck,UPMC,UPF,UT,VU,UniPi,Roche (Switzerland),Johnson & Johnson (United States),UH,UCL,CUSTODIX,INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE,Ealing Hospital NHS Trust,IRIS,PFIZER,KCL,VIB,BII GMBH,UCB,GNUBILA FRANCE,AP-HP,UM,CCL,Janssen (Belgium),IDIAP Jordi Gol,GENOMEDICS,BIPS,University of Leicester,EMBL,University of Exeter,E LTD,University of Aveiro,MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN,THE CHANCELLOR, MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE,ERASMUS MC,MPG,SOSETE,AE,University of Manchester,TEKNOLOGIAN TUTKIMUSKESKUS VTT OY,FONDAZIONE PENTA-FOR THE TREATMENT AND CARE OF CHILDREN WITH HIV-ONLUS,AUH,PHARMO,UAntwerpen,PROVINCIA LOMBARDO VENETA ORDINE OSPEDALIERO DI SAN GIOVANNI DI DIO - FATEBENEFRATELLI,KI,UOXF,University of Glasgow,LG,SYNAPSE RESEARCH MANAGEMENT PARTNERS SL,UEF,Amgen,BRIGHTON COLLABORATION FOUNDATION,VCK,UCPH,Sorbonne University,concentris,Leipzig University,STICHTING VUMC,GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.,ARSFunder: European Commission Project Code: 115372more_vert Open Access Mandate for Publications and Research data assignment_turned_in Project2019 - 2024Partners:UNIGE, Uppsala University, EU, TAK, RS +52 partnersUNIGE,Uppsala University,EU,TAK,RS,UNIBO,University of Ferrara,ARS,SARD,THE SYNERGIST,Lareb,KI,UKZN ,Johnson & Johnson (United States),FISABIO,UCB,CHUV,University of Manchester,Janssen (Belgium),Newcastle upon Tyne Hospitals NHS Foundation Trust,Centre Hospitalier Universitaire de Toulouse,BIONOTUS,NOVARTIS,REGION UPPSALA,AbbVie,UU,SGUL,i-HD,UMC,Ellegaard Göttingen Minipigs A/S,GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.,RIVM,Teva Pharmaceuticals (Israel),EFGCP,Novo Nordisk,THL,EMEA,ELEVATE,INSERM,PNO-LSH,KUL,UMCG,UiO,PFIZER,[no title available],Swansea University,COVANCE,ORCION BV,CNR,STICHTING ENTIS (EUROPEAN NETWORK TERATOLOGY INFORMATION SERVICES) FOUNDATION,MHRA,TAKEDA,MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN,Eli Lilly and Company Limited,BBMRI-ERIC,BMS,EIWHFunder: European Commission Project Code: 821520Overall Budget: 28,782,500 EURFunder Contribution: 15,300,000 EURConcePTION partners have united around a shared vision that we have a societal obligation to radically and rapidly reduce uncertainty about the safety of medication use in pregnancy and lactation. What do we deliver? ConcePTION aims to create a paradigm shift in how we study medication safety in pregnancy. We will establish (1) a successful, sustainable open-science based EU non-proprietary ecosystem of public and private stakeholders, pregnant women and researchers to generate and disseminate timely and reliable evidence on drugs across maternal, neonatal and long term outcomes of medication exposure in pregnancy and breastfeeding (2) a catalogue with fully characterized data sources for rapid selection of suitable data sources; 3) operational, business, network, information and data governance models, (4) quality assured and tested methodological approaches, analytical tools and data platforms allowing for distributed analyses, (5) procedures and tools for collection of digital data and samples directly from pregnant women, (6) In vitro, in silico and in vivo models for prediction of drug transfer in human milk, (7) a biobank and analytical network for quantification of drug in human milk, (8) best practice documents endorsed by regulators and health authorities and (9) a web-based drug information knowledge bank. How do we deliver? (1) Experienced leaders, able to manage challenging networks and public-public or public-private partnerships. (2) Defragmentation by connecting all key stakeholders and EU networks in this area. (3) Re-use of data, tools and foreground from prior European commission funded projects. (4) Connecting to leaders of similar initiatives in the USA, Canada, Asia and other parts of the world. (5) Systematic consensus & endorsement building. (6) Quality throughout as a precondition to trust the results and information by all users.
more_vert